UCP2 and pancreatic neoplasm: In models of acute pancreatitis (AP), UCP2 knockdown inhibits the proliferation of pancreatic stellate cells (Muller et al. 2016), and modulates macrophage redox responses, impacting the progression of KRAS-associated pancreatic cancer (Raho et al. 2020).